Progenity

Progenity is a California-based biotechnology company that develops and commercializes molecular testing products for hereditary cancer screening. Read more

Harry Stylli's photo - Chairman & CEO of Progenity

Chairman & CEO

Harry Stylli

CEO Approval Rating

99/100

Founded:

2011

Status:

PublicIndependent CompanyNASDAQPROG

PROGENITY TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Natera is one of Progenity's top rivals. Natera was founded in San Carlos, California} in 2004. Like Progenity, Natera also competes in the Biotechnology space. Compared to Progenity, Natera generates $367.3M more revenue.

Myriad is Progenity's #2 competitor. Myriad was founded in 1991, and is headquartered in Salt Lake City, Utah. Like Progenity, Myriad also operates in the Biotechnology space. Myriad generates $484.1M more revenue vs. Progenity.

Invitae is a top competitor of Progenity. Invitae's headquarters is in San Francisco, California, and was founded in 2010. Like Progenity, Invitae also works within the Biotechnology sector. Invitae generates 388% of Progenity's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Centogene a competitor of Progenity?

Progenity Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$82M

Progenity's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 183.6M. Over the last four quarters, Progenity's revenue has grown by 42%. Specifically, in Q1 2021's revenue was $24.5M; in Q4 2020, it was $14.3M; in Q3 2020, it was $25.9M; in Q2 2020, Progenity's revenue was $17.3M.

Progenity Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Medimetrics Personalized Drug Delivery B.V

Sep 2019

Source »
undisclosed
Medimetrics designs, develops and manufactures ingestible medical devices.

These are all the companies that Progenity has acquired. Progenity's latest acquisition was Medimetrics Personalized Drug Delivery B.V in Sep 2019. Medimetrics designs, develops and manufactures ingestible medical devices.

Progenity Funding History

Since Progenity was founded in 2011, it has participated in 12 rounds of funding. In total Progenity has raised $517.2M. Progenity's last funding round was on Jun 2021 for a total of $40.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Jun 2021
$40M
-
Post-IPO Equity
May 2021
--
-
Private Placement
Feb 2021
$25M
-
Post-IPO Debt
Dec 2020
$85.5M
-
IPO
Jun 2020
$100M
-

Since Progenity was founded in 2011, it has participated in 12 rounds of funding. In total Progenity has raised $517.2M. Progenity's last funding round was on Jun 2021 for a total of $40.0M

Progenity Investments

No recent investments found related to Progenity

These are all the companies that Progenity has invested in. Progenity's latest investment was Medimetrics Personalized Drug Delivery B.V in Sep 2019. Medimetrics designs, develops and manufactures ingestible medical devices.

Progenity News

June 10, 2021BioSpace

Progenity Announces $40 Million Private Placement

Progenity, Inc. today announced that it has entered into a definitive securities purchase agreement w... See more »
May 26, 2021Benzinga

Progenity's Targeted Delivery Of Adalimumab Shows Encouraging Action In Animal Models Induced With Colitis

Progenity Inc (NASDAQ: PROG) has announced results from a preclinical study evaluating the delivery o... See more »
May 24, 2021Markets Insider

Progenity Announces Poster Presentations at Digestive Disease Week 2021

SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnolo... See more »
May 21, 2021Markets Insider

Progenity Joins Global Call to Raise Awareness of Preeclampsia in Pregnancy on World Preeclampsia Day - May 22nd

SAN DIEGO, May 21, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company w... See more »
May 13, 2021Genomeweb

Progenity Q1 Revenues Up 46 Percent

The company also said the number of tests performed in the quarter declined 3 percent from the fourth... See more »
May 11, 2021BioSpace

Progenity Receives Funding from Crohn's & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD

Progenity , Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success ... See more »

Progenity Press Releases

May 26, 2021centralcharts

Progenity Provides Results from Key Study for Its Targeted Therapeutics Program

SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- Progenity , Inc. (Nasdaq: PROG), an innovative biotechnol... See more »
May 13, 2021centralcharts

Progenity Provides Corporate Update and Reports First Quarter 2021 Financial Results

Reports revenues of $24.5 million in the first quarter of 2021, up 72% from prior quarter Announced p... See more »
May 5, 2021GlobalNewswire

Progenity Provides Key Update Regarding its Preecludia Test for Preeclampsia

Pre-validation study demonstrates commercial laboratory systems readiness; data show strong performan... See more »
March 3, 2021Cision Canada

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG

/CNW/ -- Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. ("Silk Road"... See more »
February 11, 2021NewsFile

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG

New York, New York--(Newsfile Corp. - February 11, 2021) - Pomerantz LLP is investigating claims on b... See more »
November 17, 2020GlobalNewswire

PROG) shares announced by Shareholders Foundation

SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsu... See more »

Progenity Videos

August 13, 2015Progenity Vimeo Channel

"gcs-espanol-v4" on VIMEO

Cast: Progenity... See more »
August 13, 2015Progenity Vimeo Channel

"nipt-espanol-v4" on VIMEO

Cast: Progenity... See more »

Social Media

Progenity Headquarters

4330 La Jolla Village Drive Suite 200

San Diego, California92122

1-855-293-2639

Driving Directions »

Trending Companies

Progenity Summary

ABOUT

Overview

Progenity is a California-based biotechnology company that develops and commercializes molecular testing products for hereditary cancer screening. Progenity was founded in 2011. Progenity's headquarters is located in San Diego, California, USA 92122. ...

CEO

Progenity's Chairman & CEO, Harry Stylli, currently has an approval rating of 99%. Progenity's primary competitors are Natera, Myriad & Invitae.

Frequently Asked Questions about Progenity

  1. When was Progenity founded?

    Progenity was founded in 2011
  2. Who is Progenity's CEO?

    Progenity's CEO is Harry Stylli
  3. How much revenue does Progenity generate?

    Progenity generates $82M in revenue
  4. How much funding does Progenity have?

    Progenity has historically raised $517.2M in funding
  1. Where is Progenity's headquarters?

    Progenity's headquarters is in San Diego California, USA
  2. How many employees does Progenity have?

    Progenity has 674 employees
  3. What sector does Progenity operate in?

    Progenity is in Biotechnology
  4. Who are Progenity's competitors?

    Progenity's top competitors are Natera, Myriad, Invitae